$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
他比特定治疗白血病效果如何呢?
2025-10-19 11:44:20
Check Details
他比特定在治疗白血病这方面效果如何?
2025-10-19 11:44:20
Check Details
他比特定2020年价格
2025-10-19 11:44:20
Check Details
2020年他比特定上市了吗?
2025-10-19 11:44:20
Check Details
他比特定入医保了没?
2025-10-19 11:44:20
Check Details
他比特定医保后的价格
2025-10-19 11:44:20
Check Details
他比特定适应症有什么?
2025-10-19 11:44:20
Check Details
怎么使用他比特定?
2025-10-19 11:44:20
Check Details
他比特定该如何购买?
2025-10-19 11:44:20
Check Details
他比特定售价多少一盒呢?
2025-10-19 11:44:20
Check Details
他比特定目前已知获批适应症有什么?
2025-10-19 11:44:20
Check Details
用他比特定治疗时需要注意什么?
2025-10-19 11:44:20
Check Details
1
2
...
364
365
366
367
368
369
370
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
2
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
3
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
4
A Key Therapeutic Breakthrough Against T315I-Mutant CML
5
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
6
Tafasitamab and Lenalidomide Combination Therapy Guide
7
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
8
Gilteritinib Professional Medication Guide & Dosage Management
9
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
10
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia
11
Ixazomib & Pomalidomide in Multiple Myeloma: Mechanisms & Clinical Insights
12
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation